Autologous Bone Marrow Mononuclear Cell Therapy is Safe and Promotes Amputation Free Survival in Patients with Critical Limb Ischemia

OBJECTIVE: The purpose of this phase I open label non-randomized trial was to assess the safety and efficacy of autologous bone marrow mononuclear cell (ABMNC) therapy in promoting amputation free survival (AFS) in patients with critical limb ischemia (CLI). METHODS: Between September 2005 and March...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Murphy, Michael P., Lawson, Jeffrey H., Rapp, Brian M., Dalsing, Michael C., Klein, Janet, Wilson, Michael G., Hutchins, Gary D., March, Keith L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3102148/
https://ncbi.nlm.nih.gov/pubmed/21514773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvs.2011.01.074
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados